Incidence of cardiovascular events among tildrakizumab-treated patients with moderate-to-severe plaque psoriasis: pooled data from three large randomised clinical trials
Por:
Bissonnette, R, Fernandez-Penas, P, Puig, L, Mendelsohn, AM, Rozzo, SJ, Menter, A
Publicada:
1 ene 2020
Ahead of Print:
1 ago 2019
Resumen:
Filiaciones:
Bissonnette, R:
Innovaderm Res, Montreal, PQ, Canada
Fernandez-Penas, P:
Westmead Hosp, Dept Dermatol, Westmead, NSW, Australia
Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
Puig, L:
Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Barcelona, Spain
Mendelsohn, AM:
Sun Pharmaceut Ind Inc, Princeton, NJ USA
Rozzo, SJ:
Sun Pharmaceut Ind Inc, Princeton, NJ USA
Menter, A:
Texas A&M Coll Med, Baylor Scott & White, Div Dermatol, Dallas, TX USA
|